BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 16387076)

  • 1. Influence of mismatching of HLA cross-reactive groups on cadaveric kidney transplantation.
    Hwang SH; Oh HB; Shin ES; Yew M; Kim SC; Han DJ
    Transplant Proc; 2005 Dec; 37(10):4194-8. PubMed ID: 16387076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CREG matching for first cadaveric kidney transplants (TNX) performed by SEOPF centers between October 1987 and September 1995. Southeastern Organ Procurement Foundation.
    Thompson JS; Thacker LR
    Clin Transplant; 1996 Dec; 10(6 Pt 2):586-93. PubMed ID: 8996747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-reactive group matching does not lead to a better allocation and survival of donor kidneys.
    Stobbe I; van der Meer-Prins EM; de Lange P; Oudshoorn M; De Meester J; Doxiadis II; Claas FH
    Transplantation; 2000 Jul; 70(1):157-61. PubMed ID: 10919594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The changing role of HLA matching.
    Cecka JM
    Clin Transpl; 1986; ():141-55. PubMed ID: 3154392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA matching: identification of permissible HLA mismatches.
    Maruya E; Takemoto S; Terasaki PI
    Clin Transpl; 1993; ():511-20. PubMed ID: 7918185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of HLA matching on renal transplant survival.
    Zhou YC; Cecka JM
    Clin Transpl; 1993; ():499-510. PubMed ID: 7918184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased late hepatic artery thrombosis rate and decreased graft survival after liver transplants with zero cross-reactive group mismatches.
    Sawyer RG; Pelletier SJ; Spencer CE; Pruett TL; Isaacs RB
    Liver Transpl; 2000 Mar; 6(2):229-36. PubMed ID: 10719025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of HLA mismatches, shared cross-reactive antigen groups, and shared HLA-DR antigens on the outcome after pediatric liver transplantation.
    Sieders E; Hepkema BG; Peeters PM; TenVergert EM; de Jong KP; Porte RJ; Bijleveld CM; van den Berg AP; Lems SP; Gouw AS; Slooff MJ
    Liver Transpl; 2005 Dec; 11(12):1541-9. PubMed ID: 16315307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of HLA mismatching on graft survival in living-donor kidney transplants: Catholic Medical Center, 1984 to 1993.
    Yoon YS; Jin DC; Yang CW; Kim SY; Bang BK; Kim WI; Koh YB
    Clin Transpl; 1993; ():275-83. PubMed ID: 7918161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA compatibility and liver transplant outcome. Improved patient survival by HLA and cross-matching.
    Nikaein A; Backman L; Jennings L; Levy MF; Goldstein R; Gonwa T; Stone MJ; Klintmalm G
    Transplantation; 1994 Oct; 58(7):786-92. PubMed ID: 7940711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does re-exposure to mismatched HLA antigens decrease renal re-transplant allograft survival?
    Farney AC; Matas AJ; Noreen HJ; Reinsmoen N; Segall M; Schmidt WJ; Gillingham K; Najarian JS; Sutherland DE
    Clin Transplant; 1996 Apr; 10(2):147-56. PubMed ID: 8664509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of HLA cross-reactive group matching on graft survival in deceased donor kidney recipients.
    Lazda VA; Mozes MF
    Transplant Proc; 2005 Mar; 37(2):661-3. PubMed ID: 15848493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refinement of permissible HLA mismatches.
    Takemoto S; Terasaki PI
    Clin Transpl; 1994; ():451-66. PubMed ID: 7547575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA compatibility and organ transplant survival. Collaborative Transplant Study.
    Opelz G; Wujciak T; Döhler B; Scherer S; Mytilineos J
    Rev Immunogenet; 1999; 1(3):334-42. PubMed ID: 11256424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA amino acid residue matching.
    Takemoto SK
    Clin Transpl; 1996; ():397-425. PubMed ID: 9286585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cadaver-donor renal retransplants.
    Cho YW; Cecka JM
    Clin Transpl; 1993; ():469-84. PubMed ID: 7918181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved kidney graft survival through HLA-DR-MT matching.
    Müller GA; Müller C; Wernet P
    Proc Eur Dial Transplant Assoc; 1983; 19():464-8. PubMed ID: 6348746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of donor age and acute rejection episodes on long-term graft survival in cadaveric kidney transplantations.
    Emiroğlu R; Yagmurdur MC; Karakayali F; Haberal C; Ozcelik U; Colak T; Haberal M
    Transplant Proc; 2005 Sep; 37(7):2954-6. PubMed ID: 16213272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of human leukocyte antigen matching on long-term outcome after lung transplantation.
    Wisser W; Wekerle T; Zlabinger G; Senbaclavaci O; Zuckermann A; Klepetko W; Wolner E
    J Heart Lung Transplant; 1996 Dec; 15(12):1209-16. PubMed ID: 8981206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.